Former Maryland Medical Cannabis Commission Executive Director starts January 1, 2020
Frederick, MD (January 1, 2020) – Green Leaf Medical, LLC (dba “gLeaf”) is pleased to announce the appointment of Joy Strand as Executive Vice President beginning January 1, 2020. Strand is the immediate past Executive Director of the Maryland Medical Cannabis Commission (MMCC).
Strand led the MMCC through tremendous growth and success. During her tenure, the number of qualifying medical cannabis patients more than tripled, as did the number of businesses licensed to grow, process, and dispense medical cannabis throughout Maryland. Strand is known nationally as a leader in the cannabis industry, and she will be sharing her expertise and knowledge at speaking engagements at cannabis industry events on behalf of gLeaf.
Strand has more than 40 years’ experience in healthcare. Prior to her role at the MMCC, she served as the CEO of healthcare systems in Michigan and Maryland. In addition, Strand is a member of the 2017 graduating class of Leadership Maryland, a competitive, statewide professional development program comprised of local business and community leaders.
“We are delighted to have Ms. Strand join the gLeaf team as Executive Vice President,” says Philip Goldberg, CEO of Green Leaf Medical. “Her background in healthcare and patient safety, coupled with her expertise in organizational leadership will offer significant contributions to gLeaf as we continue to provide high-quality medical cannabis, and as our business continues to expand.” As Executive Vice President, Strand will manage Government Relations on behalf of gLeaf.
In 2019, gLeaf partnered with former Philadelphia Mayor Michael Nutter to serve as Senior Advisor for Community Relations and Engagement. Strand will work with Mayor Nutter and gLeaf’s Executive Team to develop strategies to further expand gLeaf’s footprint in communities throughout the States in which gLeaf holds licenses.
Based in Frederick, Maryland, Green Leaf Medical has a proven track record of profitable operations throughout the mid-Atlantic Region. “Rather than spending millions to acquire our core assets, the company relies on winning cannabis licenses organically through competitive application processes”, said Goldberg. Green Leaf Medical currently holds cannabis licenses in Maryland, Pennsylvania, Virginia and Ohio, with a pending application for a vertical license in New Jersey. The company is rapidly expanding with construction projects in both Maryland and Virginia that are expected to triple their annual production capacity to 50,000 pounds of dry cannabis. Green Leaf Medical saw year over year revenue double, with 2019 revenue in excess of $20 million with positive EBITDA and projects approximately $100 million of revenue for 2020 (See Disclaimer below).
Green Leaf Medical is currently raising capital from “accredited investors” via a Regulation D Private Placement to be used for acquisitions and operations. Accredited investors interested in learning more should contact: